Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2007

01-06-2007 | Review

Evaluating the organization and delivery of breast cancer services: use of performance measures to identify knowledge gaps

Authors: A. Gagliardi, F. C. Wright, M. L. Quan, D. McCready

Published in: Breast Cancer Research and Treatment | Issue 2/2007

Login to get access

Abstract

Objectives

This paper identifies gaps in our knowledge about the quality of breast cancer care in Canada to understand where programs and resources are required to enhance health services and research capacity.

Methods

A modified Delphi approach was employed involving a 15-member multidisciplinary panel of health professionals and two rounds of rating followed by deliberation to develop evidence- and consensus-based performance measures. A literature search for Canadian health services research in breast cancer was conducted based on the indicator topics. Eligible articles were identified in indexed databases of medical literature and funded research from 1995 to 2006.

Results

The multidisciplinary panel selected 34 indicators spanning access to services, patient outcomes, diagnosis and staging, surgery, adjuvant therapy, pathology, and follow-up care. A total of 78 articles (66 quantitative; 12 exploratory) on these topics were reviewed. Apart from two aspects of care (communication of treatment options, supportive care), the yield of Canadian breast cancer health services research did not increase subsequent to a review conducted 10 years ago which recommended greater efforts in this area.

Conclusions

Research involving quantitative and qualitative methods is needed to increase our understanding about the organization and delivery of services for breast cancer diagnosis, treatment and follow-up care. Since it is unclear how to balance competing research demands, innovative strategies are required to assemble resources for health services research on breast cancer. This could include the promotion of partnerships between researchers and policy-makers across jurisdictions, and the pooling of resources between organizations, regions or networks.
Appendix
Available only for authorised users
Literature
1.
Ugnat AM, Xie L, Semenciw R et al (2005) Survival patterns for the top four cancers in Canada: the effects of age, region and period. Eur J Cancer Prev 14:91–100PubMedCrossRef
2.
McCready D, Holloway C, Shelley W et al (2005) Surgical management of early stage invasive breast cancer: a practice guideline. Can J Surg 48:185–194PubMed
3.
Eccles M, Grimshaw J, Walker A, Johnston M, Pitts N (2005) Changing the behavior of healthcare professionals: the use of theory in promoting the uptake of research findings. J Clin Epidemiol 58(2):107–112PubMedCrossRef
4.
Hortobagyi GN, de la Garza Salazar J, Pritchard K et al (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6:391–401PubMedCrossRef
5.
Hebert-Croteau N, Brisson J, Latreille J et al (2005) Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ 161:951–955
6.
Paszat LF, Groome PA, Schulze K et al (2000) A population-based study of the effectiveness of breast conservation for newly diagnosed breast cancer. Int J Radiat Oncol Biol Phys 46:345–353PubMedCrossRef
7.
Goel V (1998) Health services research in breast cancer: background paper for a Canadian Breast Cancer Research Initiative workshop. Cancer Prev Control 2:173–178PubMed
8.
Gagliardi AR, Simunovic M, Langer B et al (2005) Development of quality indicators for colorectal cancer surgery, using a 3-step modified Delphi approach. Can J Surg 48:441–452PubMed
9.
Jones J, Hunter D (1995). Consensus methods for medical and health services research. BMJ 311:376–380PubMed
10.
Bairati I, Fillion L, Meyer FA, Henry C, Larochelle M (2006) Women’s perceptions of events impeding or facilitating the detection, investigation and treatment of breast cancer. Eur J Cancer Care 15:183–193CrossRef
11.
Simunovic MI, Paterson CA, Coates AJ, Wrigth JR, Levine MN (2005) Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993–2000. Can J Surg 48:137–142PubMed
12.
Olson DW (2002) How long do patients wait for elective general surgery? Can J Surg 45:31–33PubMed
13.
Mayo NE, Scott SC, Shen N, Hanley J, Goldberg MS, MacDonald N (2001) Waiting time for breast cancer surgery in Quebec. CMAJ 164:1133–1138PubMed
14.
Olivotto IA, Bancei C, Goel V, Snider J, McAuley RG, Irvine B et al (2001) Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ 165:277–283PubMed
15.
Benk V, Przybysz R, McGowan T, Paszat L (2006) Waiting times for radiation therapy in Ontario. Can J Surg 49:16–21PubMed
16.
Johnston GM, MacGarvie VL, Elliott D, Dewar RA, MacIntyre MM, Nolan MC (2004) Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992–2000. Clin Invest Med 27:142–156PubMed
17.
Rayson D, Chiasson D, Dewar R (2004). Elapsed time from breast cancer detection to first adjuvant therapy in a Canadian province, 1999–2000. CMAJ 170:957–961PubMed
18.
Shen N, Mayo NE, Scott SC, Hanley JA, Goldberg MS, Abrahamowicz M, Tamblyn R (2003) Factors associated with pattern of care before surgery for breast cancer in Quebec between 1992 and 1997. Med Care 41:1353–1366PubMedCrossRef
19.
Townsley C, Pond GR, Peloza B, Kok J, Naidoo K, Dale D et al (2005). Analysis of treatment practices for elderly cancer patients in Ontario, Canada. J Clin Oncol 23:3802–3810PubMedCrossRef
20.
Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D et al (2006) Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 24:848–855PubMedCrossRef
21.
Truong PT, Lee J, Kader HA, Speers CH, Olivotto IA (2005). Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy. Eur J Cancer 41:1267–1277PubMedCrossRef
22.
Weir L, Speers C, D’yachkova Y, Olivotto IA (2002) Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol 20:1793–1799PubMedCrossRef
23.
Trudeau ME, Pritchard KI, Chapman JA, Hanna WM, Kahn HJ, Murray D et al (2005) Prognostic factors affecting the natural history of node-negative breast cancer. Breast Cancer Res Treat 89:35–45PubMedCrossRef
24.
Froud PJ, Mates D, Jackson JS, Phillips N, Andersen S, Jackson SM et al (2000) Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 46:363–372PubMedCrossRef
25.
Demers AA, Turner D, Mo D, Kliewer EV (2005) Breast cancer trends in Manitoba: 40 years of follow-up. Chronic Dis Can 26:13–19PubMed
26.
Chaudhry R, Goel V, Sawka C (2001) Breast cancer survival by teaching status of the initial treating hospital. CMAJ 164:183–188PubMed
27.
Hebert-Croteau N, Brisson J, Lemaire J, Latreille J, Pineault R (2005) Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer. Cancer 104:1343–1348PubMedCrossRef
28.
Goodwin PJ, Ennis M, Bordeleau LJ, Pritchard KI, Trudeau ME, Koo J, Hood N (2004) Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. J Clin Oncol 22:4184–4192PubMedCrossRef
29.
Porter GA, McMulkin H, Lovrics PJ (2003) Sentinel lymph node biopsy in breast cancer: Canadian practice patterns. Ann Surg Oncol 10:255–260PubMedCrossRef
30.
Chua B, Olivotto IA, Donald JC, Hayashi AH, Davis N, Rusnak CH (2003) Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia. Can J Surg 46:273–278PubMed
31.
Chua B, Olivotto IA, Donald JC, Hayashi AH, Doris PJ, Turner LJ et al (2003) Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001. Am J Surg 185:118–126PubMedCrossRef
32.
Hack TF, Degner LF, Watson P, Sinha L (2006). Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psychooncology 15:9–19PubMedCrossRef
33.
Charles CA, Whelan T, Gafni A, Willan A, Farrell S (2003) Shared treatment decision making: what does it mean to physicians? J Clin Oncol 21:932–936PubMedCrossRef
34.
Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O’Neil J et al (1997) Information needs and decisional preferences in women with breast cancer. JAMA 277:1485–1492PubMedCrossRef
35.
Bilodeau BA, Degner LF (1996) Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum 23:691–696PubMed
36.
Mohide EA, Whelan TJ, Rath D, Gafni A, Willan AR, Czukar D et al (1996) A randomised trial of two information packages distributed to new cancer patients before their initial appointment at a regional cancer centre. Br J Cancer 73:1588–1593PubMed
37.
Charles C, Gafni A, Whelan T (2004) Self-reported use of shared decision-making among breast cancer specialists and perceived barriers and facilitators to implementing this approach. Health Expect 7:338–348PubMedCrossRef
38.
Bakker DA, Fitch MI, Gray R, Reed E, Bennett J (2001) Patient-health care provider communication during chemotherapy treatment: the perspectives of women with breast cancer. Patient Educ Couns 43:61–71PubMedCrossRef
39.
McWilliam CL, Brown JB, Stewart M (2000) Breast cancer patients’ experiences of patient–doctor communication: a working relationship. Patient Educ Couns 39:191–204PubMedCrossRef
40.
Temple W, Toews J, Fidler H, Lockyer JM, Taenzer P, Parboosingh EJ (1998) Concordance in communication between surgeon and patient. Can J Surg 41:439–445PubMed
41.
Whelan T, Levine M, Willan A, Gafni A, Sanders K, Mirsky D et al (2004) Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA 292:435–441PubMedCrossRef
42.
Whelan T, Sawka C, Levine M, Gafni A, Revno L, Willan A et al (2003) Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst 95:581–587PubMedCrossRef
43.
Hack TF, Pickles T, Bultz BD, Ruether JD, Weir LM, Degner LF, Mackey JR (2003) Impact of providing audiotapes of primary adjuvant treatment consultations to women with breast cancer: a multisite, randomized, controlled trial. J Clin Oncol 21:4138–4144PubMedCrossRef
44.
Davison BJ, Degner LF (2002) Feasibility of using a computer-assisted intervention to enhance the way women with breast cancer communicate with their physicians. Cancer Nurs 25:417–424PubMedCrossRef
45.
Goel V, Sawka CA, Thiel EC, Gort EH, O’Connor AM (2001) Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer. Med Decis Making 21:1–6PubMedCrossRef
46.
Sawka CA, Goel V, Mahut CA, Taylor GA, Thiel EC, O’Connor AM et al (1998) Development of a patient decision aid for choice of surgical treatment for breast cancer. Health Expect 1: 23–36PubMedCrossRef
47.
Paszat LF, Groome PA, Schulze K, Holowaty EJ, Mackillop WJ (2000) A population-based study of the effectiveness of breast conservation for newly diagnosed breast cancer. Int J Radiat Oncol Biol Phys 46:345–353PubMedCrossRef
48.
Hislop TG, Coldman AJ, Olivotto IA, D’yachkova Y, Speers C (2003) Local and regional therapy for women with breast cancer in British Columbia. Breast J 9: 192–199PubMedCrossRef
49.
Petrik DW, McCready DR, Goel V, Pinfold SP, Sawka CA (2003) The rate of breast conserving surgery for early breast cancer is not influenced by the surgical strategy of excisional biopsy followed by the definitive procedure. Breast J 7: 158–165CrossRef
50.
Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L (1999) Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ 161:951–955PubMed
51.
Goel V, Olivotto I, Hislop TG, Sawka C, Coldman A, Holowaty EJ (1997). Patterns of initial management of node-negative breast cancer in two Canadian provinces. British Columbia/Ontario Working Group CMAJ 156:25–35PubMed
52.
Hislop TG, Olivotto IA, Coldman AJ, Trevisan CH, Kula J, McGregor GI, Phillips N (1996) Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia. Can J Public Health 87:390–394PubMed
53.
Truong PT, Bernstein V, Wai E, Chua B, Speers C, Olivotto IA (2002) Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. Int J Radiat Oncol Biol Phys 54:794–803PubMedCrossRef
54.
Hebert-Croteau N, Brisson J, Latreille J, Gariepy G, Blanchette C, Deschenes L (1999) Time trends in systemic adjuvant treatment for node-negative breast cancer. J Clin Oncol 17:1458–1464PubMed
55.
Thompson TA, Pusic A, Kerrigan CL, Sargeant R, Slezak S, Chang BW et al (2000) Surgeon perspectives on surgical options for early-stage breast cancer. Plast Reconstr Surg 105:910–918PubMedCrossRef
56.
Porter GA, McMulkin-Tait H (2004) Practice patterns in breast cancer surgery: Canadian perspective. World J Surg 28:80–86PubMedCrossRef
57.
Paszat LF, Mackillop WJ, Groome PA, Zhang-Salomons J, Schulze K, Holowaty E (1998) Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med 21:125–134PubMed
58.
Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L (1999) Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85:1104–1113PubMedCrossRef
59.
Chua B, Olivotto IA, Weir L, Kwan W, Truong P, Ragaz J (2004) Increased use of adjuvant regional radiotherapy for node-positive breast cancer in British Columbia. Breast J 10:38–44PubMedCrossRef
60.
Tyldesley S, Zhang-Salomons J, Groome PA, Zhou S, Schulze K, Paszat LF, Mackillop WJ (2000) Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 47:469–480PubMedCrossRef
61.
Sawka C, Olivotto I, Coldman A, Goel V, Holowaty E, Hislop TG (1997) The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer. British Columbia/Ontario Working Group. Br J Cancer 75:1534–1542PubMed
62.
Hebert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G (2004) Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol 22:3685–3693PubMedCrossRef
63.
Clemons M, Enright K, Cesta A, Charbonneau F, Chow E, Warr D et al (2004) Do physicians follow systemic treatment and funding policy guidelines? Can J Clin Pharmacol 11:168–178
64.
Verma S, Kerr-Cresswell D, Dranitsaris G, Charbonneau F, Trudeau M, Yogendran G et al (2004) Bisphosphonate use for the management of breast cancer patients with bone metastases: a survey of Canadian medical oncologists. Support Care Cancer 12:852–858PubMedCrossRef
65.
Rakovitch E, Mihai A, Pignol JP, Hanna W, Kwinter J, Chartier C et al (2004) Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Breast Cancer Res Treat 87:265–272PubMedCrossRef
66.
Maunsell E, Drolet M, Ouhoummane N, Robert J (2005) Breast cancer survivors accurately reported key treatment and prognostic characteristics. J Clin Epidemiol 58:364–369PubMedCrossRef
67.
Gray RE, James P, Manthorne J, Gould J, Fitch MI (2004) A consultation with Canadian rural women with breast cancer. Health Expect 7:40–50PubMedCrossRef
68.
Gaudine A, Sturge-Jacobs M, Kennedy M (2003) The experience of waiting and life during breast cancer follow-up. Res Theory Nurs Pract 17:153–168PubMedCrossRef
69.
Gray RE, Goel V, Fitch MI, Franssen E, Labrecque M (2002) Supportive care provided by physicians and nurses to women with breast cancer. Results from a population-based survey.Support Care Cancer 10:647–652PubMedCrossRef
70.
Richer MC, Ezer H (2002) Living in it, living with it, and moving on: dimensions of meaning during chemotherapy. Oncol Nurs Forum 29:113–119PubMed
71.
Tomiak EM, Diverty B, Verma S, Evans WK, Le Petit C, Will P, Berthelot JM (1998) Follow-up practices for patients with early stage breast cancer: a survey of Canadian oncologists. Cancer Prev Control 2: 63–71PubMed
72.
Gray RE, Fitch M, Greenberg M, Hampson A, Doherty M, Labrecque M (1998) The information needs of well, longer-term survivors of breast cancer. Patient Educ Couns 33:245–255PubMedCrossRef
73.
Whelan TJ, Mohide EA, Willan AR, Arnold A, Tew M, Sellick S et al (1997) The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer 80:1518–1524PubMedCrossRef
74.
Lauzier S, Maunsell E, De Koninck M, Drolet M, Hebert-Croteau N, Robert J (2005) Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups. Psychooncology 14:351–360PubMedCrossRef
75.
Brazil K, Whelan T, O’Brien MA, Sussan J, Pyette N, Bainbridge D (2004) Towards improving the co-ordination of supportive cancer care services in the community. Health Policy 70:125–131PubMedCrossRef
76.
Gray RE, Goel V, Fitch MI, Franssen E, Chart P, Greenberg M et al (2000). Utilization of professional supportive care services by women with breast cancer. Breast Cancer Res Treat 64:253–258PubMedCrossRef
77.
Wilson KA, Dowling AJ, Abdolell M, Tannock IF (2000) Perception of quality of life by patients, partners and treating physicians.Qual Life Res 9:1041–1052PubMedCrossRef
78.
Del Giudice ME, Leszcz M, Pritchard KI, Vincent L, Goodwin P (1997) Attitudes of Canadian oncology practitioners toward psychosocial interventions in clinical and research settings in women with breast cancer. Psychooncology 6:178–189PubMedCrossRef
79.
O’Connor AM, Llewellyn-Thomas HA, Sawka C, Pinfold SP, To T, Harrison DE (1997) Physicians’ opinions about decision aids for patients considering systemic adjuvant therapy for axillary-node negative breast cancer. Patient Educ Couns 30:143–153PubMedCrossRef
80.
Worster A, Bass MJ, Wood ML (1996) Willingness to follow breast cancer. Survey of family physicians. Can Fam Physician 42:263–268PubMed
81.
Savard J, Simard S, Ivers H, Morin CM (2005) Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol 23:6083–6096PubMedCrossRef
82.
McKenzie DC, Kalda AL (2003) Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol 21:463–466PubMedCrossRef
83.
Bordeleau L, Szalai JP, Ennis M, Leszcz M, Speca M, Sela R et al (2003) Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. J Clin Oncol 21:1944–1951PubMedCrossRef
84.
Simpson JS, Carlson LE, Trew ME (2001). Effect of group therapy for breast cancer on healthcare utilization. Cancer Pract 9: 19–26PubMedCrossRef
85.
Segal R, Evans W, Johnson D, Smith J, Colletta S, Gayton J et al (2001) Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 19:657–665PubMed
86.
Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H et al (2001). The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719–1726PubMedCrossRef
87.
Ashbury FD, Cameron C, Mercer SL, Fitch M, Nielsen E (1998) One-on-one peer support and quality of life for breast cancer patients. Patient Educ Couns 35:89–100
88.
Gray R, Fitch M, Davis C, Phillips C (1997) A qualitative study of breast cancer self-help groups. Psychooncology 6:279–289PubMedCrossRef
89.
Bigby JA, Holmes MD (2005) Disparities across the breast cancer continuum. Cancer Causes Control 16:35–44 PubMedCrossRef
90.
Kerner JF (2006). Knowledge translation versus knowledge integration: a “funder’s” perspective. J Contin Educ Health Prof 26:72–80PubMedCrossRef
91.
Canadian Cancer Society/National Cancer Institute of Canada (2006). Canadian cancer statistics. CCS/NCIC, Toronto
92.
Canadian Institutes of Health Research (2004). Finding a balance in federal health research funding. http://​www.​cihr-irsc.​gc.​ca/​e/​26467.​html.​ Cited June 27, 2006
93.
Gordon El-Bihbety D (2005) Leaders’ forum on health research in Canada: the urgent need for innovation. Health Q 8:84–86
94.
Lavis JN (2006) Research, public policymaking, and knowledge-translation processes: Canadian efforts to build bridges. J Contin Educ Health Prof 26:37–45PubMedCrossRef
95.
Francis J, Perlin JB (2006) Improving performance through knowledge translation in the Veterans Health Administration. J Contin Educ Health Prof 26:63–71PubMedCrossRef
96.
Greenberg A, Angus H, Sullivan T, Brown AD (2005) Development of a set of strategy-based system-level cancer care performance indicators in Ontario, Canada. Int J Qual Health Care 17:107–114PubMedCrossRef
97.
Lemieux-Charles L, Champagne F (eds) (2004) Using knowledge and evidence in health care—multidisciplinary perspectives. University of Toronto Press, Toronto
98.
Jack SM (2006) Utility of qualitative research findings in evidence-based public health practice. Public Health Nurs 23:277–283PubMedCrossRef
Metadata
Title
Evaluating the organization and delivery of breast cancer services: use of performance measures to identify knowledge gaps
Authors
A. Gagliardi
F. C. Wright
M. L. Quan
D. McCready
Publication date
01-06-2007
Published in
Breast Cancer Research and Treatment / Issue 2/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9359-9

Other articles of this Issue 2/2007

Breast Cancer Research and Treatment 2/2007 Go to the issue

Clinical trial

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue

CLINICAL TRAIL

A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

Review

Hormonal therapy for postmenopausal breast cancer: the science of sequencing

Epidemiology

Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case–control study

ORIGINAL PAPER

Breast cancer incidence trends in deprived and affluent Scottish women

OriginalPaper

Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits